Making a difference by being different
August 19, 2021
USA Paralympics sitting volleyball player Jillian Williams, who beat Ewing sarcoma with help from San Antonio and Houston medical teams, is going for the gold in the Tokyo Paralympics.
Yahoo!: Jillian’s Leap: Williams, who beat Ewing sarcoma with help from San Antonio and Houston medical teams, is going for the gold in Tokyo Paralympics
August 19, 2021
Dr. Aaron Sugalski, Pediatric Hematology-Oncology, Mays Cancer Center, and his patient, Jillian Williams, a member of the USA sitting volleyball team competing in the Tokyo Paralympics, are quoted in this Yahoo! story. Read story
Cancer Network: Individuals with cancer mount an acceptable immune response to COVID-19 vaccine but other strategies are needed for potential non-responders
August 16, 2021
This Cancer Network article is about a recent U.S. and Swiss study that showed that nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose. Investigators say developing alternative strategies for non-responders will be key. Read story
Jillian’s Leap: Williams, who beat Ewing sarcoma with help from San Antonio and Houston medical teams, is going for the gold in Tokyo Paralympics
August 16, 2021
Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Katrina Burton, 713-792-8034, kburton@mdanderson.org Shelley Kofler, 512-294-5224, shelley.kofler@uhs-sa.com SAN ANTONIO and HOUSTON (Aug. 16, 2021) – Making a difference by being different. USA Paralympics sitting volleyball player Jillian Williams strives to live by that principle every day, and it’s a motto she will carry with her in Tokyo at […]
Fox 29: A closer look at the pandemic’s impact on women’s health
August 2, 2021
Dr. Kate Lathrop, Hematology/Mays Cancer Center, was interviewed for this Fox 29 story about the pandemic’s impact on women’s health. Watch story
U.S. News & World Report: Almost all cancer patients respond well to COVID-19 vaccines
July 6, 2021
This U.S. News & World Report article features a new study that shows 94% of patients with cancer respond well to COVID-19 vaccines. Study co-authors are from the Mays Cancer Center and the University of Geneva. Read story.